Selected research
Industry Growth & Trends
Global Brain Imaging Modalities and Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Brain Imaging Modalities and Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Brain Imaging Modalities and Software market include Quantib, Brainomix, General Electric, Imaging Biometrics, United Imaging Healthcare Co, Siemens, Healthineers AG, Koninklijke Philips N.V. and Canon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Brain Imaging Modalities and Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Brain Imaging Modalities and Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brain Imaging Modalities and Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brain Imaging Modalities and Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Brain Imaging Modalities and Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Brain Imaging Modalities and Software Market by Company
Quantib
Brainomix
General Electric
Imaging Biometrics
United Imaging Healthcare Co
Siemens
Healthineers AG
Koninklijke Philips N.V.
Canon
Vuno
Aspect Imaging
IXICO
QMENTA
I. Analysis
Fujifilm Holdings
Other Prominent Players
Brain Imaging Modalities and Software Segment by Type
Brain Imaging Modalities
Brain Analysis Software
Brain Imaging Modalities and Software Segment by Application
Adults
Pediatrics and Infants
Brain Imaging Modalities and Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Imaging Modalities and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brain Imaging Modalities and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Imaging Modalities and Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Brain Imaging Modalities and Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Brain Imaging Modalities
- Brain Analysis Software
Applications
- Adults
- Pediatrics and Infants
Companies covered
- Quantib
- Brainomix
- General Electric
- Imaging Biometrics
- United Imaging Healthcare Co
- Siemens
- Healthineers AG
- Koninklijke Philips N.V.
- Canon
- Vuno
- Aspect Imaging
- IXICO
- QMENTA
- I. Analysis
- Fujifilm Holdings
- Other Prominent Players
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Brain Imaging Modalities and Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Brain Imaging Modalities and Software Market Size by Region (2021-2032)
- 1.4.1 Global Brain Imaging Modalities and Software Market Size by Region (2021-2026)
- 1.4.2 Global Brain Imaging Modalities and Software Market Size by Region (2027-2032)
- 1.5 Key Regions Brain Imaging Modalities and Software Market Size (2021-2032)
- 1.5.1 North America Brain Imaging Modalities and Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Brain Imaging Modalities and Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Brain Imaging Modalities and Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Brain Imaging Modalities and Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Brain Imaging Modalities and Software Market Size Growth Rate (2021-2032)
2 Brain Imaging Modalities and Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Brain Imaging Modalities
- 2.1.2 Brain Analysis Software
- 2.2 Global Brain Imaging Modalities and Software Market Size by Type
- 2.2.1 Global Brain Imaging Modalities and Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Brain Imaging Modalities and Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Brain Imaging Modalities and Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Brain Imaging Modalities and Software Market Size by Regions
- 2.3.1 North America Brain Imaging Modalities and Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Brain Imaging Modalities and Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Brain Imaging Modalities and Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Brain Imaging Modalities and Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Brain Imaging Modalities and Software Market Size Breakdown by Type (2021-2026)
3 Brain Imaging Modalities and Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Adults
- 3.1.2 Pediatrics and Infants
- 3.2 Global Brain Imaging Modalities and Software Market Size by Application
- 3.2.1 Global Brain Imaging Modalities and Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Brain Imaging Modalities and Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Brain Imaging Modalities and Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Brain Imaging Modalities and Software Market Size by Regions
- 3.3.1 North America Brain Imaging Modalities and Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Brain Imaging Modalities and Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Brain Imaging Modalities and Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Brain Imaging Modalities and Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Brain Imaging Modalities and Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Brain Imaging Modalities and Software Industry Trends
- 4.2 Brain Imaging Modalities and Software Industry Drivers
- 4.3 Brain Imaging Modalities and Software Industry Opportunities and Challenges
- 4.4 Brain Imaging Modalities and Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Brain Imaging Modalities and Software Revenue (2021-2026)
- 5.2 Global Brain Imaging Modalities and Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Brain Imaging Modalities and Software Key Company Headquarters & Area Served
- 5.4 Global Brain Imaging Modalities and Software Company, Product Type & Application
- 5.5 Global Brain Imaging Modalities and Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Brain Imaging Modalities and Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Brain Imaging Modalities and Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Brain Imaging Modalities and Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Quantib
- 6.1.1 Quantib Company Information
- 6.1.2 Quantib Business Overview
- 6.1.3 Quantib Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Quantib Brain Imaging Modalities and Software Product Portfolio
- 6.1.5 Quantib Recent Developments
- 6.2 Brainomix
- 6.2.1 Brainomix Company Information
- 6.2.2 Brainomix Business Overview
- 6.2.3 Brainomix Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Brainomix Brain Imaging Modalities and Software Product Portfolio
- 6.2.5 Brainomix Recent Developments
- 6.3 General Electric
- 6.3.1 General Electric Company Information
- 6.3.2 General Electric Business Overview
- 6.3.3 General Electric Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 General Electric Brain Imaging Modalities and Software Product Portfolio
- 6.3.5 General Electric Recent Developments
- 6.4 Imaging Biometrics
- 6.4.1 Imaging Biometrics Company Information
- 6.4.2 Imaging Biometrics Business Overview
- 6.4.3 Imaging Biometrics Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Imaging Biometrics Brain Imaging Modalities and Software Product Portfolio
- 6.4.5 Imaging Biometrics Recent Developments
- 6.5 United Imaging Healthcare Co
- 6.5.1 United Imaging Healthcare Co Company Information
- 6.5.2 United Imaging Healthcare Co Business Overview
- 6.5.3 United Imaging Healthcare Co Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 United Imaging Healthcare Co Brain Imaging Modalities and Software Product Portfolio
- 6.5.5 United Imaging Healthcare Co Recent Developments
- 6.6 Siemens
- 6.6.1 Siemens Company Information
- 6.6.2 Siemens Business Overview
- 6.6.3 Siemens Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Siemens Brain Imaging Modalities and Software Product Portfolio
- 6.6.5 Siemens Recent Developments
- 6.7 Healthineers AG
- 6.7.1 Healthineers AG Company Information
- 6.7.2 Healthineers AG Business Overview
- 6.7.3 Healthineers AG Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Healthineers AG Brain Imaging Modalities and Software Product Portfolio
- 6.7.5 Healthineers AG Recent Developments
- 6.8 Koninklijke Philips N.V.
- 6.8.1 Koninklijke Philips N.V. Company Information
- 6.8.2 Koninklijke Philips N.V. Business Overview
- 6.8.3 Koninklijke Philips N.V. Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Koninklijke Philips N.V. Brain Imaging Modalities and Software Product Portfolio
- 6.8.5 Koninklijke Philips N.V. Recent Developments
- 6.9 Canon
- 6.9.1 Canon Company Information
- 6.9.2 Canon Business Overview
- 6.9.3 Canon Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Canon Brain Imaging Modalities and Software Product Portfolio
- 6.9.5 Canon Recent Developments
- 6.10 Vuno
- 6.10.1 Vuno Company Information
- 6.10.2 Vuno Business Overview
- 6.10.3 Vuno Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Vuno Brain Imaging Modalities and Software Product Portfolio
- 6.10.5 Vuno Recent Developments
- 6.11 Aspect Imaging
- 6.11.1 Aspect Imaging Company Information
- 6.11.2 Aspect Imaging Business Overview
- 6.11.3 Aspect Imaging Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Aspect Imaging Brain Imaging Modalities and Software Product Portfolio
- 6.11.5 Aspect Imaging Recent Developments
- 6.12 IXICO
- 6.12.1 IXICO Company Information
- 6.12.2 IXICO Business Overview
- 6.12.3 IXICO Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 IXICO Brain Imaging Modalities and Software Product Portfolio
- 6.12.5 IXICO Recent Developments
- 6.13 QMENTA
- 6.13.1 QMENTA Company Information
- 6.13.2 QMENTA Business Overview
- 6.13.3 QMENTA Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 QMENTA Brain Imaging Modalities and Software Product Portfolio
- 6.13.5 QMENTA Recent Developments
- 6.14 I. Analysis
- 6.14.1 I. Analysis Company Information
- 6.14.2 I. Analysis Business Overview
- 6.14.3 I. Analysis Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 I. Analysis Brain Imaging Modalities and Software Product Portfolio
- 6.14.5 I. Analysis Recent Developments
- 6.15 Fujifilm Holdings
- 6.15.1 Fujifilm Holdings Company Information
- 6.15.2 Fujifilm Holdings Business Overview
- 6.15.3 Fujifilm Holdings Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Fujifilm Holdings Brain Imaging Modalities and Software Product Portfolio
- 6.15.5 Fujifilm Holdings Recent Developments
- 6.16 Other Prominent Players
- 6.16.1 Other Prominent Players Company Information
- 6.16.2 Other Prominent Players Business Overview
- 6.16.3 Other Prominent Players Brain Imaging Modalities and Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Other Prominent Players Brain Imaging Modalities and Software Product Portfolio
- 6.16.5 Other Prominent Players Recent Developments
7 North America
- 7.1 North America Brain Imaging Modalities and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Brain Imaging Modalities and Software Market Size by Country (2021-2026)
- 7.3 North America Brain Imaging Modalities and Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Brain Imaging Modalities and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Brain Imaging Modalities and Software Market Size by Country (2021-2026)
- 8.3 Europe Brain Imaging Modalities and Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Brain Imaging Modalities and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Brain Imaging Modalities and Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Brain Imaging Modalities and Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Brain Imaging Modalities and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Brain Imaging Modalities and Software Market Size by Country (2021-2026)
- 10.3 South America Brain Imaging Modalities and Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Brain Imaging Modalities and Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Brain Imaging Modalities and Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Brain Imaging Modalities and Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst